Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
5
×
life sciences
national blog main
5
×
san francisco blog main
biotech
boston blog main
boston top stories
clinical trials
national top stories
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
blueprint medicines
bristol-myers squibb
cell therapy
deals
diagnostics
drugs
eli lilly
fda
immunotherapy
loxo oncology
What
drug
5
×
new
5
×
bio
cancer
companies
lead
roundup
targets
advance
advantages
approval
approved
bar
biogen’s
biologic
biology
biopharmaceutical
biotech
black
brings
clinic
convo
cytokine
deeper
demonstrating
diamond
diego’s
dna
drugs
earlier
eluded
enhanced
expect
failures
fda
fingerprint
gamble
genetic
going
hopes
Language
unset
Current search:
new
×
cancer
×
drug
×
" national blog main "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs